Ascendis Pharma A/S - Product Pipeline Review - 2014

Published: Sep, 2014 | Pages: 24 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Ascendis Pharma A/S - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Ascendis Pharma A/S - Product Pipeline Review - 2014', provides an overview of the Ascendis Pharma A/S's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Ascendis Pharma A/S's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Ascendis Pharma A/S including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Ascendis Pharma A/S's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Ascendis Pharma A/S's pipeline products

Reasons to buy

- Evaluate Ascendis Pharma A/S's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Ascendis Pharma A/S in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Ascendis Pharma A/S's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Ascendis Pharma A/S and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ascendis Pharma A/S
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Ascendis Pharma A/S and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Ascendis Pharma A/S Snapshot 4
Ascendis Pharma A/S Overview 4
Key Information 4
Key Facts 4
Ascendis Pharma A/S - Research and Development Overview 5
Key Therapeutic Areas 5
Ascendis Pharma A/S - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Ascendis Pharma A/S - Pipeline Products Glance 9
Ascendis Pharma A/S - Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Ascendis Pharma A/S - Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Discovery Products/Combination Treatment Modalities 11
Ascendis Pharma A/S - Drug Profiles 12
ACP-001 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
ACP-005 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
ACP-006 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
ACP-007 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
ACP-008 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Ascendis Pharma A/S - Pipeline Analysis 17
Ascendis Pharma A/S - Pipeline Products by Target 17
Ascendis Pharma A/S - Pipeline Products by Route of Administration 18
Ascendis Pharma A/S - Pipeline Products by Molecule Type 19
Ascendis Pharma A/S - Pipeline Products by Mechanism of Action 20
Ascendis Pharma A/S - Recent Pipeline Updates 21
Ascendis Pharma A/S - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
Coverage 23
Secondary Research 23
Primary Research 23
Expert Panel Validation 23
Contact Us 24
Disclaimer 24

List of Tables
Ascendis Pharma A/S, Key Information 4
Ascendis Pharma A/S, Key Facts 4
Ascendis Pharma A/S - Pipeline by Indication, 2014 6
Ascendis Pharma A/S - Pipeline by Stage of Development, 2014 7
Ascendis Pharma A/S - Monotherapy Products in Pipeline, 2014 8
Ascendis Pharma A/S - Phase II, 2014 9
Ascendis Pharma A/S - Preclinical, 2014 10
Ascendis Pharma A/S - Discovery, 2014 11
Ascendis Pharma A/S - Pipeline by Target, 2014 17
Ascendis Pharma A/S - Pipeline by Route of Administration, 2014 18
Ascendis Pharma A/S - Pipeline by Molecule Type, 2014 19
Ascendis Pharma A/S - Pipeline Products by Mechanism of Action, 2014 20
Ascendis Pharma A/S - Recent Pipeline Updates, 2014 21
Ascendis Pharma A/S, Subsidiaries 22